欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0718/001
药品名称Priligy
活性成分
    • Dapoxetine hydrochloride 30.0 mg
剂型Film-coated tablet
上市许可持有人Phoenix Labs Unlimited Company
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      Priligy 30 mg Filmtabletten
    • Austria (AT)
      Priligy 30 mg Filmtabletten
    • Spain (ES)
    • Portugal (PT)
      Priligy
    • Italy (IT)
    • Finland (FI)
    • Croatia (HR)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Greece (GR)
    • Poland (PL)
      Priligy
    • Lithuania (LT)
      Priligy 30 mg plėvele dengtos tabletės
    • Estonia (EE)
    • Bulgaria (BG)
      Priligy
    • Cyprus (CY)
      PRILIGY 30mg TABS
    • Czechia (CZ)
      Priligy
    • Hungary (HU)
      PRILIGY 30 mg filmtabletta
    • Malta (MT)
      MA018/03101
    • Romania (RO)
      Priligy 30 mg comprimate filmate
    • Slovenia (SI)
    • Slovakia (SK)
      Priligy
许可日期2008/12/17
最近更新日期2025/09/25
药物ATC编码
    • G04BX14 dapoxetine
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase